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PrevalenceAbstract Background: Glucose-6-phosphate dehydrogenase (G6PD) is a house keeping enzyme
which catalyzes the first step in the hexose monophosphate pathway of glucose metabolism.
G6PD deficiency is the commonest hemolytic X-linked genetic disease, which affects approximately
400 million people worldwide. The prevalence rate of G6PD deficiency varies worldwide with a
higher prevalence in malarial endemic population. In India several studies were published and
reported with varying incidences of this disease in different populations.
Objective: The aim of the present study was to assess the overall frequency of G6PD deficiency
in the Indian population using meta-analysis.
Methods: PubMed, Science Direct, Google Scholar and Springer Link databases were searched
for studies that investigated G6PD deficiency in Indian population. If any author studied different
sub-populations we treated the study as an independent study.
Results: A total of 72 studies with a total sample size of 38,565 and 2,623 G6PD deficient sub-
jects were included in the present meta-analysis. Meta-analysis was performed in both fixed and
random effect models. Meta-analysis with random model showed an overall prevalence proportion
as 0.085 (95% CI = 0.070–0.103; p= 0.000; tau = 0.826; I2 = 0.486; Cochran Q = 0.999).
Conclusion: In conclusion the present meta-analysis confirms the overall magnitude of the fre-
quency of G6PD deficiency (8.5%) in the Indian population.
 2016 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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Google Scholar and Springer 
Link databases searched 
243 articles retrieved 
Non relevant =124 
117 articles remaining 
Molecular analyses= 52
65 articles 
Overlapping data= 23; 
Not from India= 9 
33 articles suitable for 
inclusion in the meta-analysis 
Figure 1 Flow diagram of selection of studies.1. Introduction
Glucose 6-phosphate dehydrogenase (G6PD) deficiency was
discovered half a century ago and is still the most common
inherited enzymopathy. Clinically, deficiency of this enzyme
affects as many as 400 million individuals worldwide [1]. This
inherited deficiency causes neonatal hyperbilirubinemia and
chronic hemolytic anemia. Although most affected individuals
are asymptomatic, exposure to oxidative stresses such as cer-
tain drugs or infection, can elicit acute hemolysis. G6PD defi-
ciency was first identified in American blacks (African and
Asian descent) in the course of studies of sensitivity to the
hemolytic effect of primaquine [2]. Soon after G6PD deficiency
was also reported from Mediterranean populations and it
became apparent that the enzyme deficiency in the Mediter-
ranean population was much more severe than the prototype
deficiency that had been found in American blacks [3].
In 1986, the G6PD gene was cloned independently by Per-
sico et al. [4] and Takizawa et al. [5]. G6PD gene is located
on the long arm of the X chromosome (Xq28), and consists
of 13 exons [6]. G6PD locus is thought to be one of the most
polymorphic loci among humans with almost 300 allelic vari-
ants reported [7]. The G6PD enzyme monomer consists of
515 residues with over 59 kDa molecular weight. It was
reported that the enzymatically active form of G6PD is either
a dimer or tetramer of a single polypeptide subunit according
to cellular pH [8].
2. Methods
2.1. Searched strategy and identification of studies
For the present meta-analysis PubMed, Science Direct, Springer
link andGoogle scholar databaseswere searched for suitable arti-
cles using keywords ‘‘G6PD deficiency” and ‘‘Glucose 6 phos-
phate dehydrogenase deficiency”. Since the retrieved article list
was too long only the studies carried out in India were taken into
consideration. The included articles were also hand searched for
additional studies which can be included in this study.
2.2. Inclusion and exclusion criteria
The inclusion criteria for the studies were as follows: studies:
(1) should be original and published, (2) that used only Indian
samples. Studies were excluded if they were: (1) molecular
analyses, (2) case reports, and (3) reviews and editorials.
2.3. Data extraction
From all the eligible studies the following information was
extracted: first authors’ family name, year of publication,population/ethnic group, the number of samples analyzed,
the number of G6PD deficient subjects and journal name. If
in any study samples were taken from multiple caste/race then
information was abstracted separately for each caste.
2.4. Statistical analysis
Prevalence proportion (PP) was computed from the number of
deficient and sample sizes (N) with the corresponding 95%
confidence interval (CI) from each study. A pooled PP was
then estimated on the basis of the individual PPs. The PP
was estimated either by using fixed effects [9] or random effects
[10] model depending upon heterogeneity. The heterogeneity
between studies was tested using the Q-statistics and quantified
using the I2 statistic [11]. If I2 > 50% then random effect
model was used [12]. Publication bias was investigated by
using the funnel plots. All p values are two tailed with a signif-
icance level at 0.05. All statistical analyses were undertaken by
computer program Meta-analyst.
Table 1 Details of studies included in the meta-analysis.







Baxi, 1961 Maharashtra Mixed 110 15 13.64 Curr. Sci; 30: 16–17
Baxi, 1963 Maharashtra Parsee 216 34 15.74 Indian J. Med. Sci; 17: 493–500
Chatterjea, 1966 India Mixed 173 8 4.62 Bull. World Health Organ; 35: 837–
856
Deshmukh, 1968 Maharashtra Mahar 100 10 10 Indian J. Med. Res; 56; 821–825
Kate, 1978 Maharashtra, West
Bengal
Mixed 993 75 7.55 Hum. Genet; 44: 339–343
Ghosh, 1981 West Bengal Mixed 490 21 4.28 Hum. Hered; 31: 119–121
Saha, 1987 West Bengal Lepchas 215 0 0 Hum Hered;37:113–21
Chhotray, 1990 Orissa Juang 53 7 13.20 Indian J Med Res;;92: 443–446
Chhotray, 1990 Orissa Munda 52 6 11.54 Indian J Med Res. 92: 443–446.
Chhotray, 1990 Orissa Bhuyan 102 15 14.71 Indian J Med Res; 92: 443–446
Verma, 1990 Punjab Mixed 1000 39 3.9 Indian J Pediatr; 57: 385–8
Jain, 1922 Rajasthan Mixed 9433 170 1.80 J Assoc Physicians India; 40: 662–3
Kaede, 1995 Orissa Bhuyan 204 30 14.71 Am J Hum Genet; 57:1335–1341
Kaede, 1995 Orissa Bhatudi 106 12 11.32 Am J Hum Genet; 57:1335–1341
Kaede, 1995 Orissa Munda 104 14 13.46 Am J Hum Genet; 57:1335–1341
Kaede, 1995 Orissa Santhal 53 6 11.32 Am J Hum Genet; 57:1335–1341
Kaede, 1995 Orissa Koda 56 5 8.93 Am J Hum Genet; 57:1335–1341
Kaede, 1995 Orissa Saunti 52 4 7.69 Am J Hum Genet; 57:1335–1341
Kaede, 1995 Orissa Juang 57 7 12.28 Am J Hum Genet; 57:1335–1341
Kaede, 1995 Orissa Ganda 49 3 6.12 Am J Hum Genet; 57:1335–1341
Kaede, 1995 Orissa Pana 216 8 3.70 Am J Hum Genet; 57:1335–1341
Kaede, 1995 Madhya Pradesh Baiga 263 11 4.18 Am J Hum Genet; 57:1335–1341
Kuruvilla, 1998 India Mixed 212 25 11.79 Indian Ped; 35:52–55
Joshi, 2001 Western India Vataliya Prajapati 385 87 22.59 Haematologia 31: 57–60 (Budap)
Murhekar, 2001 Andaman and
Nicobar Islands
Negrito tribe 29 1 3.45 Hum. Biol. 73: 739–744
Sukumar, 2004 India Mixed 3166 332 10.49 Blood Cells Mol. Diseases 33: 141–
145
Santhi, 2004 Haryana Jat 136 13 9.56 Anthropologist; 6(4): 291–292
Santhi b, 2004 Haryana Brahmin 152 14 9.21 Anthropologist; 6(4): 291–292
Chhotray, 2004 Orissa Juang 879 115 13.08 Annual Report of RMRC (ICMR),
Bhubaneswar; 46–47
Chhotray, 2004 Orissa Bodo 839 3 0.36 Annual Report of RMRC (ICMR),
Bhubaneswar; 46–47
Chhotray, 2004 Orissa Didayi 1014 17 1.68 Annual Report of RMRC (ICMR),
Bhubaneswar; 46–47
Chhotray, 2004 Orissa Kondh 645 51 7.91 Annual Report of RMRC (ICMR),
Bhubaneswar; 46–47
Balgir, 2004 Orissa Bathudi 95 13 13.68 Anthropologist; 6: 69–75
Balgir, 2004 Orissa Bhatra 166 14 8.43 Anthropologist; 6: 69–75
Balgir, 2004 Orissa Bhumiz 116 20 17.24 Anthropologist; 6: 69–75
Balgir, 2004 Orissa Bhuyan 92 12 13.04 Anthropologist; 6: 69–75
Balgir, 2004 Orissa Gond 219 25 11.41 Anthropologist; 6: 69–75
Balgir, 2004 Orissa Kharia 54 6 11.11 Anthropologist; 6: 69–75
Balgir, 2004 Orissa Kisan 130 8 6.15 Anthropologist; 6: 69–75
Balgir, 2004 Orissa Kolha 102 19 18.63 Anthropologist; 6: 69–75
Balgir, 2004 Orissa Kondh 254 28 11.02 Anthropologist; 6: 69–75
Balgir, 2004 Orissa Lodha 78 7 8.97 Anthropologist; 6: 69–75
Balgir, 2004 Orissa Munda 96 25 26.04 Anthropologist; 6: 69–75
Balgir, 2004 Orissa Oraon 104 11 10.58 Anthropologist; 6: 69–75
Balgir, 2004 Orissa Paraja 176 49 27.84 Anthropologist; 6: 69–75
Balgir, 2004 Orissa Santhal 100 15 15 Anthropologist; 6: 69–75
Balgir, 2004 Orissa Saora 177 28 15.82 Anthropologist; 6: 69–75
Gupte, 2005 Gujarat Vataliya Prajapati 1644 358 21.78 Indian J. Med. Sci. 59 (2005) 51–56
Saraswathy, 2005 New Delhi Brahmin 147 4 2.72 Anthropologist; 7(1): 69–70
Pao M, 2005 India Mixed 2479 50 2.02 Indian J Pediatr;72:835–7
Dash, 2005 Mizoram Mizos 490 86 17.55 Indian J Pathol Microbiol;48:17–8
Balgir, 2006 Central Eastern
India
Mixed 1959 186 9.49 Homo 57 (2006) 163–176
(continued on next page)
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Table 1 (continued)







Bhasin, 2006 Jammu & Kashmir Mixed 124 7 5.64 Int J Hum Genet; 6(1): 49–72
Bhasin, 2006 Nagaland Naga 85 23 27.06 Int J Hum Genet; 6(1): 49–72
Bhasin, 2006 Karnataka Mixed 87 0 0 Int J Hum Genet; 6(1): 49–72
Bhasin, 2006 Kerala Mixed 1809 22 1.22 Int J Hum Genet; 6(1): 49–72
Bhasin, 2006 Assam Mixed 558 49 8.78 Int J Hum Genet; 6(1): 49–72
Nishank, 2008 Orissa Tribal 3480 223 6.41 Ann. Hum. Biol; 35: 355–361
Saraswathy a, 2008 Andhra Pradesh Koyadoras 132 6 4.54 Anthropologist; 10(2): 163–165
Saraswathy b, 2008 Andhra Pradesh Nayakpoda 40 2 5 Anthropologist; 10(2): 163–165
Samtani, 2008 Dadra and Nagar
Haveli
Warli tribe 79 8 10.13 Anthropologist; 10(4): 301–303
Devi, 2009 Dadra and Nagar
Haveli
Rajputs 47 1 2.13 Anthropologist, 11(1): 45–47
Achoubi, 2010 Manipur Muslim 136 29 21.32 Anthropological Science; 118(3):
201–204.
Achoubi, 2010 Manipur Brahmin 127 12 9.45 Anthropological Science; 118(3):
201–204
Achoubi, 2010 Manipur Kabui 51 4 7.84 Anthropological Science; 118(3):
201–204
Sharma, 2010 Uttar Pradesh Dangurai Tharu 56 13 23.21 Anthropologist; 12(1): 59–61
Sharma, 2010 India Mixed 810 50 6.17 Indian J Pathol Microbiol; 54(4)
850–851
Kabita a, 2011 Himachal Pradesh Rajput 65 1 1.54 Anthropologist; 13(1): 39–41
Kabita b, 2011 Himachal Pradesh Brahmin 47 1 2.13 Anthropologist; 13(1): 39–41
Rai and Kumar,
2012
Uttar Pradesh Scheduled Caste 200 20 10 J Anthrop. doi:10.1155/2012/984180
Kumar and
Rai,2012
Uttar Pradesh Yadav 200 7 3.5 Res. Environ. Life Sci; 5(4): 213–214
Rai and
Kumar,2014
Uttar Pradesh Muslim 200 26 13 Indian J Hum Genet; 20(1): 96–97
298 P. Kumar et al.3. Results
The preliminary search resulted in 243 publications from
PubMed, Google scholar, Science Direct, and Springer Link.
Out of which 124 were irrelevant for the present meta-
analysis, which includes reviews, editorials, book chapters,
case reports, etc. After initial exclusion of 124 articles, total
117 articles remained. Out of which, in 52 articles molecular
analyses were carried out, 23 articles reported overlapping data
and 9 were not from India. Thus, a total of 33 articles were
included in present meta-analysis. The search workflow was
shown in Fig. 1.
Study characteristics were summarized in Table 1. Thirty-
three articles that reported G6PD deficiency from different
parts of India were found suitable for the inclusion in the pre-
sent meta-analysis [13–47]. All studies were published between
the periods of 1961 and 2014. A few authors studied several
different caste populations, so each population was included
as an individual study. A total of 72 populations were studied
in thirty-three articles. All these thirty-three studies were per-
formed in different states of the India, Maharashtra
[16,17,23,29], West Bengal [25,29,36], Orissa [14,20,21,30,35],
Punjab [44], Rajasthan [27], Madhya Pradesh [30], Western
India [27], Central Eastern India [15], Uttar Pradesh
[32,37,38,44], Andaman and Nicobar [35], Haryana [41],
Gujarat [26], New Delhi [42], Mizoram [22], Jammu and Kash-
mir [18], Nagaland [18], Karnataka [18], Kerala [18], Assam
[18], Andhra Pradesh [43], Dadra and Nagar Haveli [24,40],
Manipur [13], and Himachal Pradesh [29].In thirty-three studies included in the present meta-analysis,
the smallest sample size was 29 [35], and highest sample size
was 9,433 [27]. Totally 8,565 samples were analyzed, out of
which 2,626 individuals were G6PD deficient.
Meta-analysis was performed using both fixed and random
effect models. Meta-analysis with Fixed effects model showed
0.096 (95% CI = 0.093–0.100) (Fig. 2). Meta-analysis with
random effect model showed an overall prevalence proportion
as 0.087 (95% CI = 0.070–0.103; p = 0.000; tau = 0.826;
I2 = 0.486; Cochran Q= 0.999) (Fig. 3). Publication bias
was absent (Fig. 4).
4. Discussion
According to World Health Organization [48] the prevalence
of G6PD deficiency in India ranges 0–10% which is population
specific and is reported to be higher among tribals in compar-
ison to caste population [49]. In general, the frequency of
G6PD deficient allele is comparatively higher in North and
West India, which indicates considerable stability of the allele
in these areas, whereas in South India it is uniformly low
except in Andhra Pradesh and Tamil Nadu. Bhasin [18]
reported the distribution of G6PD deficient (Gd) allele
according to natural regions, climatic regions, Himalayan
regions, and different ethnic groups. In the Himalayan region,
the frequency is quite high (0.087) as compared to non–Hima-
layan region (0.043) and frequency of G6PD deficient allele in
scheduled tribes is high (0.055) as compared to other ethnic
groups.
Figure 2 Forest plot of prevalence proportion of fixed effect model.
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(Gd) allele was published from all the states and also in sev-
eral caste groups like-Parsee [17], Muslim [13], Brahmin
[13,29,42,43,50], Jat [42], Rajputs [24,29,31,50], and Scheduled
caste [38,46]. Bhasin [9] reviewed that G6PD deficiency in
India varies from 1% to 27% in different communities and
regions of India. The review shows varying frequencies in dif-
ferent regions and ethnic groups depending upon the hyperen-
demicity of malaria. In eastern India, the frequency is thehighest in Angami Nagas (27.1%), followed by Adi (19.4%),
Apatani (16.7%), Nishi (16%), Rabha (15.8%), Mikir
(15.6%), Santhal (14.1%), etc. [51]. In western India, higher
frequency is found in the Vataliya Prajapati (caste) community
(27.9%), Gonds (24.4%), Warli (19.5%), Parsis (15.7%),
Madia (14.4%), Kutchi Bhanushalis (13%), etc. In the North,
high frequency has been shown in Meghwal-Chamars (15.1%)
and Punjabi Khatris (14%) for this defective enzyme. In South
India, high incidence of G6PD deficiency is found in the tribals
Figure 3 Forest plot of prevalence proportion of random effect model.
300 P. Kumar et al.(13%) of Andhra Pradesh and Kurumba tribe (11.9%) of
Kerala [51]. The frequency of G6PD deficiency in Dhelki
Kharia subtribe (30.4%) is the highest so far reported from
India.
As an important statistical method developed recently,
meta-analysis quantitatively combines several small analysis
of the same topic with low statistical power and small number
of participants and with a homogeneous design. Because of the
large sample sizes, meta-analysis has more statistical power
than a single study to obtain reliable results. Several meta-
analysis studies were already published, which investigated
effects of gene variants in disease causing or prevalence pro-portion of pathogenic variants in different populations to
assess small effect of MTHFR C677T polymorphism as risk
factor for different diseases [52,53].
Early detection and prevention is the key strategy for the
successful management and control of G6PD deficiency. The
G6PD deficient individuals are asymptomatic (until they are
exposed to oxidative stress) so they transmit pathogenic
mutated gene to the next generation. In addition, G6PD defi-
ciency carriers are partially protected against malarial infec-
tion hence this mutation is naturally selected in malarial
endemic regions of India. The results of the present meta-
analysis determined the exact magnitude of the G6PD defi-
Figure 4 Forest plot:standard error versus PP.
Glucose-6-phosphate dehydrogenase deficiency in India 301ciency in Indian population i.e. 8.5%, which can aid in plan-
ning programs to improve neonatal health and also help to
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